Machine learning model helps drug discovery
Source: CC0 Public Domain

Machine learning model helps drug discovery

Tandem mass spectrometry is a powerful analytical tool used to characterize complex mixtures in drug discovery and other fields. Now, Purdue University scientists have created a new method of applying machine learning concepts to the tandem mass spectrometry process to improve the flow of information in the development of new drugs.

"Mass spectrometry plays an integral role in drug discovery and development," said Gaurav Chopra, an assistant professor of analytical and physical chemistry in Purdue's College of Science. "The specific implementation of bootstrapped machine learning with a small amount of positive and negative training data presented here will pave the way for becoming mainstream in day-to-day activities of automating characterization of compounds by chemists."

Chopra said there are two major problems in the field of machine learning used for chemical sciences. Methods used do not provide chemical understanding of the decisions that are made by the algorithm, and new methods are not typically used to do blind experimental tests to see if the proposed models are accurate for use in a chemical laboratory.

"We have addressed both of these items for a methodology that is isomer selective and extremely useful in chemical sciences to characterize complex mixtures, identify chemical reactions and drug metabolites, and in fields such as proteomics and metabolomics," Chopra said.

The Purdue researchers created statistically robust machine learning models to work with less training data—a technique that will be useful for drug discovery. The model looks at a common neutral reagent—called 2-methoxypropene (MOP) - and predicts how compounds will interact with MOP in a tandem mass spectrometer in order to obtain structural information for the compounds. "This is the first time that machine learning has been coupled with diagnostic gas-phase ion-molecule reactions, and it is a very powerful combination, leading the way to completely automated mass spectrometric identification of organic compounds," said Hilkka Kenttämaa, the Frank Brown Distinguished Professor of Analytical Chemistry and Organic Chemistry. "We are now introducing many new reagents into this method."

The Purdue team introduces chemical reactivity flowcharts to facilitate chemical interpretation of the decisions made by the machine learning method that will be useful to understand and interpret the mass spectra for structural information.

The work is published in Chemical Science.

Subscribe to our newsletter

Related articles

AI predicts unknown links between viruses and mammals

AI predicts unknown links between viruses and mammals

A new study could help scientists mitigate the future spread of zoonotic and livestock diseases caused by existing viruses.

Deep learning predicts viral infections

Deep learning predicts viral infections

Using fluoresence images from live cells, researchers have trained an artificial neural network to reliably recognize cells that are infected by adenoviruses or herpes viruses.

A robot scientist is ready for drug discovery

A robot scientist is ready for drug discovery

The robot scientist Eve has been assembled and is now operating at Chalmers University of Technology. Eve’s f​irst mission is to identify and test drugs against Covid-19.​

Microfluidics: efficiently smuggling drugs into cells

Microfluidics: efficiently smuggling drugs into cells

Progressive Mechanoporation makes it possible to mechanically disrupt the membranes of cells for a short time period and let drugs or genes inside cells.

AI makes great microscopes better than ever

AI makes great microscopes better than ever

Machine learning helps some of the best microscopes to see better, work faster, and process more data.

Designing better antibody drugs with machine learning

Designing better antibody drugs with machine learning

Artificial intelligence could help to optimise the development of antibody drugs. This leads to active substances with improved properties, also with regard to tolerability in the body.

AI platform to assess blood vessel anomalies

AI platform to assess blood vessel anomalies

Researchers have developed an AI platform that could one day be used in a system to assess vascular and eye diseases.

Machine learning speeds up drug discovery

Machine learning speeds up drug discovery

Researchers have developed a machine learning-based technique that speeds speeds up calculations of drug molecules' binding affinity to proteins.

Breast cancer-on-a-chip tests immunotherapy drugs

Breast cancer-on-a-chip tests immunotherapy drugs

Researchers have successfully designed and tested a system for rapid testing of large numbers of potential immunotherapy drugs.

Popular articles

Subscribe to Newsletter